Nano-Bio Innovation Seminar

When: Wednesday, February 20, 2013 at 4:40 pm
Where: SH 335
Speaker: Douglas W. Jamison
Organization: Chairman of the Board, Chief Executive Officer & Managing Director, Harris & Harris VC
Sponsor: IGERT Nanomedicine Science & Technology

Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009; as President
and Chief Operating Officer from January 2005 to December 2008; as Treasurer from March 2005 to
May 2008; as a Managing Director since January 2004; as Chief Financial Officer from January 2005
to December 2007; and as Vice President from September 2002 to December 2004. He has been a
member of our Board of Directors since May 2007. Since January 2009, he has served as Chairman
and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the
Company, since 2005, he has served as a Director; and from January 2005 to December 2008 he
served as President. From 1998 to 2002, Mr. Jamison worked as a Senior Technology Manager at
the University of Utah Technology Transfer Office, where he managed intellectual property for the
University of Utah. This included assessing technologies in both the biological sciences and the
physical sciences, working with patent attorneys to develop patent protection, and developing and
marketing these technologies with industry. He is a Co-Editor-in-Chief, Journal of Nanotechnology
Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association and a
member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board. He was
graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).
Portfolio responsibilities: Ancora Pharmaceuticals, Mersana Therapeutics, Metabolon, Nextreme
Thermal Solutions and Solazyme.